comparemela.com

Latest Breaking News On - French gaap - Page 1 : comparemela.com

Bic : UNIVERSAL REGISTRATION DOCUMENT 2023 -March 28, 2024 at 07:43 am EDT

Pharnext Reports Financial Results for Year-End 2020

Pharnext Reports Financial Results for Year-End 2020 DJ Pharnext Reports Financial Results for Year-End 2020 Pharnext Pharnext Reports Financial Results for Year-End 2020 27-Apr-2021 / 19:00 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. = Pharnext Reports Financial Results for Year-End 2020 PARIS, France, April 27, 2021, 7:00 p.m. CET - Pharnext SA (FR0011191287 - ALPHA) (the Company ), an advanced late-stage clinical biopharmaceutical company pioneering new approaches to developing innovative drug combinations based on big genomics data and artificial intelligence using its PLEOTHERAPY platform, today announces its financial results for the fiscal year ended December 31, 2020.

Pharnext Reports Financial Results for Year-End -2-

Pharnext Reports Financial Results for Year-End -2- DJ Pharnext Reports Financial Results for Year-End 2020 Pharnext Pharnext Reports Financial Results for Year-End 2020 27-Apr-2021 / 19:00 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. = Pharnext Reports Financial Results for Year-End 2020 PARIS, France, April 27, 2021, 7:00 p.m. CET - Pharnext SA (FR0011191287 - ALPHA) (the Company ), an advanced late-stage clinical biopharmaceutical company pioneering new approaches to developing innovative drug combinations based on big genomics data and artificial intelligence using its PLEOTHERAPY platform, today announces its financial results for the fiscal year ended December 31, 2020.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.